CAPTRUST Financial Advisors
HZNP

CAPTRUST Financial Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

CAPTRUST Financial Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,444
Closed -$514K – 2868
2023
Q3 		$514K Sell
4,444
-17
-0.4% -$1.83K ﹤0.01% 1629
2023
Q2 		$459K Buy
4,461
+527
+13% +$55.6K ﹤0.01% 1671
2023
Q1 		$429K Sell
3,934
-1,226
-24% -$136K ﹤0.01% 1487
2022
Q4 		$587K Buy
5,160
+342
+7% +$28.4K ﹤0.01% 1253
2022
Q3 		$298K Sell
4,818
-3,319
-41% -$232K ﹤0.01% 1548
2022
Q2 		$649K Buy
8,137
+1,812
+29% +$172K ﹤0.01% 1032
2022
Q1 		$665K Sell
6,325
-1,381
-18% -$135K ﹤0.01% 1020
2021
Q4 		$830K Buy
7,706
+699
+10% +$76.3K 0.01% 892
2021
Q3 		$768K Buy
7,007
+313
+5% +$32.5K 0.01% 856
2021
Q2 		$627K Buy
6,694
+1,700
+34% +$156K 0.01% 907
2021
Q1 		$460K Buy
4,994
+3,976
+391% +$336K 0.01% 992
2020
Q4 		$74K Sell
1,018
-20
-2% -$1.49K ﹤0.01% 1659
2020
Q3 		$83K Sell
1,038
-36
-3% -$2.48K ﹤0.01% 1420
2020
Q2 		$59K Buy
+1,074
New +$45.9K ﹤0.01% 1563
2019
Q4 		– Sell
-274
Closed -$7K – 2045
2019
Q3 		$7K Sell
274
-162
-37% -$4.19K ﹤0.01% 1609
2019
Q2 		$10K Hold
436
– – ﹤0.01% 1510
2019
Q1 		$12K Sell
436
-330
-43% -$7.82K ﹤0.01% 1358
2018
Q4 		$15K Hold
766
– – ﹤0.01% 1118
2018
Q3 		$15K Hold
766
– – ﹤0.01% 1120
2018
Q2 		$13K Buy
+766
New +$11.7K ﹤0.01% 1099

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

CAPTRUST Financial Advisors's HZNP Position: Q4 2023 in Review

CAPTRUST Financial Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 4,444 shares — an estimated $514K sold.

CAPTRUST Financial Advisors first reported a position in HZNP in Q2 2018 and held it in 20 quarters. The position peaked at $830K in Q4 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • CAPTRUST Financial Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 4,444 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $514K.
  • CAPTRUST Financial Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2018 and held it in 20 quarters.
  • CAPTRUST Financial Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $830K in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.